Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma

• Published in: Nuclear medicine Vol. 53; no. 2; p. 26
• Main Authors: Pak, K, Kim, S-J, Kim, I J, Kim, D U, Kim, K, Kim, H, Kim, S J
• Format: Journal Article
• Language: English
• Published: Germany 01.01.2014
• Subjects: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms - diagnostic imaging; Bile Duct Neoplasms - mortality; Bile Ducts, Intrahepatic - diagnostic imaging; Bile Ducts, Intrahepatic - metabolism; Cholangiocarcinoma - diagnostic imaging; Cholangiocarcinoma - metabolism; Cholangiocarcinoma - mortality; Female; Fluorodeoxyglucose F18 - pharmacokinetics; Humans; Male; Middle Aged; Positron-Emission Tomography - statistics & numerical data; Prevalence; Prognosis; Radiopharmaceuticals - pharmacokinetics; Reproducibility of Results; Republic of Korea - epidemiology; Risk Assessment; Sensitivity and Specificity; Spleen - diagnostic imaging; Spleen - metabolism; Survival Rate; spleen; cholangiocarcinoma; PET

Diffuse splenic 18F-Fluorodeoxyglucose (FDG) uptake has shown to be associated with concurrent inflammation. We evaluated the prognostic value of diffuse splenic FDG uptake for predicting prognosis in cholangiocarcinoma patients. Sixty-four patients with unresectable cholangiocarcinoma performed Pos...